Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$11.17
+0.6%
$10.53
$8.27
$30.10
$335.38M1.29719,699 shs94,270 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.47
-0.6%
$9.81
$8.12
$18.23
$395.26M0.54416,561 shs120,798 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.18
+0.8%
$16.73
$14.42
$23.70
$441.48M0.99162,229 shs45,111 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$1.77
-1.4%
$2.35
$1.66
$5.86
$122.83M1.191.26 million shs560,867 shs
10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-2.37%+0.18%+18.46%-16.60%-20.03%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+6.76%+9.29%+19.73%+18.87%-3.84%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+8.69%+12.55%+6.10%+0.83%-19.17%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
+3.47%-0.56%-25.73%-26.03%-64.48%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$11.17
+0.6%
$10.53
$8.27
$30.10
$335.38M1.29719,699 shs94,270 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.47
-0.6%
$9.81
$8.12
$18.23
$395.26M0.54416,561 shs120,798 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.18
+0.8%
$16.73
$14.42
$23.70
$441.48M0.99162,229 shs45,111 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$1.77
-1.4%
$2.35
$1.66
$5.86
$122.83M1.191.26 million shs560,867 shs
10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-2.37%+0.18%+18.46%-16.60%-20.03%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+6.76%+9.29%+19.73%+18.87%-3.84%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+8.69%+12.55%+6.10%+0.83%-19.17%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
+3.47%-0.56%-25.73%-26.03%-64.48%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$14.5029.79% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.67
Moderate Buy$22.5096.23% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.82
Moderate Buy$24.4442.33% Upside
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
2.83
Moderate Buy$5.00183.29% Upside

Current Analyst Ratings Breakdown

Latest NNOX, KIDS, DCTH, and CLPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$17.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$24.00
4/24/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$25.00
4/22/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
DowngradeHoldStrong Sell
4/21/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingSell (E+)
4/20/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Reiterated RatingSell (D-)
4/20/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Reiterated RatingBuy$5.00
4/13/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Reiterated RatingBuy$5.00
4/10/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Reiterated RatingSell (E+)
3/18/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Boost Price TargetBuy$18.00 ➝ $20.00
3/5/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Lower Price TargetBuy$28.00 ➝ $18.00
(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M9.06N/AN/A$0.99 per share11.28
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.64$0.05 per share210.81$3.15 per share3.64
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M1.87$0.18 per share94.90$13.19 per share1.30
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$13.02M9.43N/AN/A$2.14 per share0.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$0.91N/AN/AN/A-69.08%-122.17%-40.69%5/13/2026 (Estimated)
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.07163.86114.66N/A3.17%2.63%2.39%5/7/2026 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%N/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$75.02M-$1.59N/AN/AN/A-790.87%-64.65%-57.27%7/20/2026 (Estimated)

Latest NNOX, KIDS, DCTH, and CLPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.25N/AN/AN/A$12.00 millionN/A
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971N/AN/AN/A$23.51 millionN/A
4/30/2026Q1 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million
4/20/2026Q4 2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.15-$0.50-$0.35-$0.50$3.99 million$3.72 million
3/17/2026Q4 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.27-$0.05-$0.27$10.40 million$10.41 million
2/26/2026Q4 2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.06-$0.05+$0.01-$0.05$20.35 million$20.73 million
2/26/2026Q4 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.37-$0.26+$0.11-$0.43$61.27 million$61.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.75
5.91
5.13
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
10.92
9.98
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.29
5.21
2.65
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
3.96
3.77

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
31.80%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11029.99 million27.91 millionOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.46 million27.79 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.69 million17.52 millionOptionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19069.59 millionN/AOptionable

Recent News About These Companies

Nano-X falls after Q4 miss, CFO transition

New MarketBeat Followers Over Time

Media Sentiment Over Time

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$11.17 +0.07 (+0.65%)
As of 12:02 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$11.47 -0.06 (-0.56%)
As of 12:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$17.18 +0.14 (+0.79%)
As of 12:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$1.76 -0.03 (-1.40%)
As of 12:02 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.